AI-generated summary
The authors irradiated the salivary gland area of streptozotocin-induced diabetic female rats with a 660 nm diode laser and measured blood glucose, plasma insulin and HMGB1 levels. They report that low-power laser irradiation significantly reduced hyperglycemia, without changing insulin or HMGB1 plasma levels, possibly by improving insulin resistance. The authors note that more studies are needed to understand the mechanisms.
- Who or what was studied
- Streptozotocin-induced diabetic female rats
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports an animal study and states that more studies are needed to understand the mechanisms, with the proposed insulin resistance explanation described only as possible.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 20 J/cm2
- Power
- 70 mW
- Total energy
- 22.4 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.